Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Charlottesville, VA
SEC filing record 1 source field available
Fiscal year end
31 December
ADIAL PHARMACEUTICALS, INC. has filed 562 SEC EDGAR filings since 16 Mar 2011

SEC filing history

Showing 426-450 of 562 matching filings.

Per page
25
Current page
18
S-3 File 333-237793

REGISTRATION STATEMENT

Filing date
22 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Mar 2020
Reporting date
27 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2020
Reporting date
25 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-38323

ANNUAL REPORT

Filing date
20 Mar 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
06 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
06 Feb 2020
Reporting date
06 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90718

ADIAL PHARMACEUTICALS, INC.

Filing date
21 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
31 Dec 2019
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
16 Dec 2019
Reporting date
12 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Dec 2019
Reporting date
12 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
14 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
04 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-233760

REGISTRATION STATEMENT

Filing date
13 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

FORM 8K

Filing date
20 Aug 2019
Reporting date
16 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
13 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
DEF 14A File 001-38323

DEFINITIVE PROXY STATEMENT

Filing date
08 Jul 2019
Reporting date
16 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
08 Jul 2019
Reporting date
05 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .